The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: A Case–Control Study

The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: A Case–Control Study

Rami Al-Dwairi, Hamzeh Rwashdeh, Moneera Otoom Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, JordanCorrespondence: Rami Al-DwairiDepartment of Special Surgery, Division of Ophthalmology, Faculty of Medicine Jordan...

Full description

Bibliographic Details
Main Authors:	Al-Dwairi RA, Rwashdeh H, Otoom M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-09-01
Series:	Therapeutics and Clinical Risk Management
Subjects:	diabetic retinopathy covid-19 lockdown intravitreal injections visual outcome risk management
Online Access:	https://www.dovepress.com/the-influence-of-covid-19-lockdown-in-jordan-on-patients-with-diabetic-peer-reviewed-fulltext-article-TCRM

Similar Items

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors
by: Al-Dwairi RA, et al.
Published: (2024-03-01)

Visual Outcome of Intravitreal Bevacizumab in Treatment of Diabetic Retinopathy
by: Kanwal Zareen Abbasi, et al.
Published: (2018-03-01)

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats
by: Yan Lu, et al.
Published: (2014-02-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Recurrent Diabetic Macular Edema: What to Do
by: Rita Santos Gonçalves, et al.
Published: (2017-09-01)

Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy
by: Dan Gong, MD, et al.
Published: (2021-09-01)

Comparison Of Intravitreal Triamcinolone Injection Vs Laser Photocoagulation in Angiographic Macular Edema in Diabetic Retinopathy
by: Somesh V Aggarwal, et al.
Published: (2012-09-01)

Intravitreal ranibizumab injections in patients with retinopathy of prematurity (ROP)
by: Zuluaga Gómez, Liliana María, et al.
Published: (2018-01-01)

Clinical Experience in the Administration of Intravitreal Injection Therapy at a Tertiary University Hospital in Jordan During the COVID-19 Lockdown
by: Saleh OA, et al.
Published: (2020-08-01)

Expert corner - diabetic retinopathy
by: R Kim, et al.
Published: (2019-01-01)

Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity
by: Qiong Zou, et al.
Published: (2022-05-01)

Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
by: Jun Xu, et al.
Published: (2020-04-01)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01)

Managing proliferative diabetic retinopathy in a patient with vitreous hemorrhage: a case report
by: O. B. Koshchynets, et al.
Published: (2022-06-01)

Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity
by: Fei Feng, et al.
Published: (2014-08-01)

Quantitative ultra-widefield fluorescein angiography biomarkers in diabetic retinopathy and association with treatment and progression
by: Iyengar RS, et al.
Published: (2024-12-01)

The Silent Threat: Understanding and Managing Diabetic Retinopathy
by: Kinga Borowiec, et al.
Published: (2024-12-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
by: Tyler A. Bahr, et al.
Published: (2023-04-01)

Efficacy of the modified staged method of surgical treatment for proliferative diabetic retinopathy
by: Vira S Ponomarchuk, et al.
Published: (2022-03-01)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
by: Aljundi W, et al.
Published: (2022-01-01)

Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01)

Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients
by: Yue Xu, et al.
Published: (2022-10-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
by: Siying Li, et al.
Published: (2022-12-01)

Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines
by: Taraprasad Das, et al.
Published: (2016-01-01)

Hypertension and Ischemic Stroke After Aflibercept for Retinopathy of Prematurity
by: Bazvand F, et al.
Published: (2020-07-01)

Letter to the Editor: Potential of Activated Growth Factor From Platelets in Diabetic Retinopathy Treatment [Letter]
by: Luthfiyah S, et al.
Published: (2025-02-01)

Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review
by: Livio Vitiello, et al.
Published: (2024-06-01)

Treatment of aggressive posterior retinopathy of prematurity accompanied by nasolacrimal duct obstruction with purulent discharge: A case report
by: Ehsan Namvar, et al.
Published: (2024-11-01)

Association of serum levels of inflammatory cytokines with retinopathy of prematurity in preterm infants
by: Xiao Chun Ling, et al.
Published: (2024-01-01)

Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review
by: Maciej Gawęcki, et al.
Published: (2023-12-01)

Assessment of the degree of diabetic neuropathy of the optic nerve following intravitreal interventions in proliferative diabetic retinopathy
by: Elhage Emhamed Ali, et al.
Published: (2016-04-01)

COVID-19 Lockdown and Eye Injury: A Case Series from Jordan
by: Alqudah AA, et al.
Published: (2020-10-01)

Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
by: Elfalah M, et al.
Published: (2021-02-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)

Determining the Superiority of Vitrectomy vs Aflibercept for Treating Dense Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Quiroz-Reyes MA, et al.
Published: (2023-08-01)

The effectiveness of vitrectomy co-adjuvant intravitreal dexamethasone implant on visual outcome in patients with proliferative diabetic retinopathy: study protocol for a prospective randomized controlled trial
by: Jipeng Li, et al.
Published: (2025-02-01)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
by: Weiwei Wang, et al.
Published: (2023-02-01)